Phytochemicals for the treatment of COVID-19

被引：18
作者：
Espano, Erica [1 ]
Kim, Jiyeon [1 ]
Lee, Kiho [1 ]
Kim, Jeong-Ki [1 ]
机构：
[1] Korea Univ, Coll Pharm, Dept Pharm, Sejong 30019, South Korea
来源：
JOURNAL OF MICROBIOLOGY | 2021年 / 59卷 / 11期
关键词：
antivirals; alkaloids; coronaviruses; COVID-19; flavonoids; phytochemicals; natural products; SARS-CoV-2; SARS-COV-2; PROTEASE; INHIBIT; ANDROGRAPHOLIDE; REPLICATION; EXTRACT; TMPRSS2;
D O I：
10.1007/s12275-021-1467-z
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
The coronavirus disease 2019 (COVID-19) pandemic has underscored the lack of approved drugs against acute viral diseases. Plants are considered inexhaustible sources of drugs for several diseases and clinical conditions, but plant-derived compounds have seen little success in the field of antivirals. Here, we present the case for the use of compounds from vascular plants, including alkaloids, flavonoids, polyphenols, and tannins, as antivirals, particularly for the treatment of COVID-19. We review current evidence for the use of these phytochemicals against SARS-CoV-2 infection and present their potential targets in the SARS-CoV-2 replication cycle.
引用
收藏
页码：959 / 977
页数：19
相关论文
共 79 条
  • [61] Pomegranate Peel Extract as an Inhibitor of SARS-CoV-2 Spike Binding to Human ACE2 Receptor (in vitro): A Promising Source of Novel Antiviral Drugs
    Tito, Annalisa
    Colantuono, Antonio
    Pirone, Luciano
    Pedone, Emilia
    Intartaglia, Daniela
    Giamundo, Giuliana
    Conte, Ivan
    Vitaglione, Paola
    Apone, Fabio
    [J]. FRONTIERS IN CHEMISTRY, 2021, 9
  • [62] Trends and strategies to combat viral infections: A review on FDA approved antiviral drugs
    Tompa, Dharma Rao
    Immanuel, Aruldoss
    Srikanth, Srimari
    Kadhirvel, Saraboji
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2021, 172 : 524 - 541
  • [63] Coronavirus biology and replication: implications for SARS-CoV-2
    V'kovski, Philip
    Kratzel, Annika
    Steiner, Silvio
    Stalder, Hanspeter
    Thiel, Volker
    [J]. NATURE REVIEWS MICROBIOLOGY, 2021, 19 (03) : 155 - 170
  • [64] Nano-curcumin therapy, a promising method in modulating inflammatory cytokines in COVID-19 patients
    Valizadeh, Hamed
    Abdolmohammadi-vahid, Samaneh
    Danshina, Svetlana
    Gencer, Mehmet Ziya
    Ammari, Ali
    Sadeghi, Armin
    Roshangar, Leila
    Aslani, Saeed
    Esmaeilzadeh, Abdolreza
    Ghaebi, Mahnaz
    Valizadeh, Sepehr
    Ahmadi, Majid
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 89
  • [65] Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease
    van de Sand, Lukas
    Bormann, Maren
    Alt, Mira
    Schipper, Leonie
    Heilingloh, Christiane Silke
    Steinmann, Eike
    Todt, Daniel
    Dittmer, Ulf
    Elsner, Carina
    Witzke, Oliver
    Krawczyk, Adalbert
    [J]. VIRUSES-BASEL, 2021, 13 (04):
  • [66] Berberine and Obatoclax Inhibit SARS-Cov-2 Replication in Primary Human Nasal Epithelial Cells In Vitro
    Varghese, Finny S.
    van Woudenbergh, Esther
    Overheul, Gijs J.
    Eleveld, Marc J.
    Kurver, Lisa
    van Heerbeek, Niels
    van Laarhoven, Arjan
    Miesen, Pascal
    den Hartog, Gerco
    de Jonge, Marien, I
    van Rij, Ronald P.
    [J]. VIRUSES-BASEL, 2021, 13 (02):
  • [67] Low dose of emetine as potential anti-SARS-CoV-2 virus therapy: preclinical in vitro inhibition and in vivo pharmacokinetic evidences
    Wang, Aoli
    Sun, Yong
    Liu, Qingwang
    Wu, Hong
    Liu, Juan
    He, Jun
    Yu, Junling
    Chen, Qing Qing
    Ge, Yinglu
    Zhang, Zhuhui
    Hu, Chen
    Chen, Cheng
    Qi, Ziping
    Zou, Fengming
    Liu, Feiyang
    Hu, Jie
    Zhao, Ming
    Huang, Tao
    Wang, Beilei
    Wang, Li
    Wang, Wei
    Wang, Wenchao
    Ren, Tao
    Liu, Jing
    Sun, Yehuan
    Fan, Song
    Wu, Qibing
    Liang, Chaozhao
    Sun, Liangdan
    Su, Bin
    Wei, Wei
    Liu, Qingsong
    [J]. MOLECULAR BIOMEDICINE, 2020, 1 (01):
  • [68] Wang SC, 2020, AM J CANCER RES, V10, P4538
  • [69] World Health Organization, 2020, WHO Coronavirus Disease (COVID-19) Dashboard
  • [70] SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target
    Xia, Bingqing
    Shen, Xurui
    He, Yang
    Pan, Xiaoyan
    Liu, Feng-Liang
    Wang, Yi
    Yang, Feipu
    Fang, Sui
    Wu, Yan
    Duan, Zilei
    Zuo, Xiaoli
    Xie, Zhuqing
    Jiang, Xiangrui
    Xu, Ling
    Chi, Hao
    Li, Shuangqu
    Meng, Qian
    Zhou, Hu
    Zhou, Yubo
    Cheng, Xi
    Xin, Xiaoming
    Jin, Lin
    Zhang, Hai-Lin
    Yu, Dan-Dan
    Li, Ming-Hua
    Feng, Xiao-Li
    Chen, Jiekai
    Jiang, Hualiang
    Xiao, Gengfu
    Zheng, Yong-Tang
    Zhang, Lei-Ke
    Shen, Jingshan
    Li, Jia
    Gao, Zhaobing
    [J]. CELL RESEARCH, 2021, 31 (08) : 847 - 860
12345678